Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8233 ARTÍCULOS , VIENDO DEL 2701 AL 2715

Nanoconstructs as a versatile tool for detection and diagnosis of Alzheimer biomarkers

Gopalan D, Pandey A, Alex AT, Kalthur G, Pandey S, Udupa N, Mutalik S.

Nanotechnology. 2021 Apr 2;32(14):142002. doi: 10.1088/1361-6528/abcdcb.

A Systematic Review on the Feasibility of Salivary Biomarkers for Alzheimer's Disease

Bouftas M.

J Prev Alzheimers Dis. 2021;8(1):84-91. doi: 10.14283/jpad.2020.57.

Dementia research in 2020: moving forward despite the COVID-19 pandemic

Kivipelto M, Mangialasche F.

Lancet Neurol. 2021 Jan;20(1):3-5. doi: 10.1016/S1474-4422(20)30453-1.

Longitudinal Associations of Blood Phosphorylated Tau181 and Neurofilament Light Chain With Neurodegeneration in Alzheimer Disease

Moscoso A, Grothe MJ, Ashton NJ, Karikari TK, Lantero Rodríguez J, Snellman A, Suárez-Calvet M, Blennow K, Zetterberg H, Schöll M; Alzheimer’s Disease Neuroimaging Initiative.

JAMA Neurol. 2021 Apr 1;78(4):396-406. doi: 10.1001/jamaneurol.2020.4986.

Polyamine biomarkers as indicators of human disease

Amin M, Tang S, Shalamanova L, Taylor RL, Wylie S, Abdullah BM, Whitehead KA.

Biomarkers. 2021 Mar;26(2):77-94. doi: 10.1080/1354750X.2021.1875506. Epub 2021 Jan 25.

Findings of Efficacy, Safety, and Biomarker Outcomes of Atabecestat in Preclinical Alzheimer Disease: A Truncated Randomized Phase 2b/3 Clinical Trial

Sperling R, Henley D, Aisen PS, Raman R, Donohue MC, Ernstrom K, Rafii MS, Streffer J, Shi Y, Karcher K, Raghavan N, Tymofyeyev Y, Bogert J, Brashear HR, Novak G, Thipphawong J, Saad ZS, Kolb H, Rofael H, Sanga P, Romano G.

JAMA Neurol. 2021 Mar 1;78(3):293-301. doi: 10.1001/jamaneurol.2020.4857.

The complexity of Alzheimer's disease: an evolving puzzle

Ferrari C, Sorbi S.

Physiol Rev. 2021 Jul 1;101(3):1047-1081. doi: 10.1152/physrev.00015.2020. Epub 2021 Jan 21.

Advances in Brain Amyloid Imaging

Krishnadas N, Villemagne VL, Doré V, Rowe CC.

Semin Nucl Med. 2021 May;51(3):241-252. doi: 10.1053/j.semnuclmed.2020.12.005. Epub 2021 Jan 19.

The contributions of metabolomics in the discovery of new therapeutic targets in Alzheimer's disease

Altiné-Samey R, Antier D, Mavel S, Dufour-Rainfray D, Balageas AC, Beaufils E, Emond P, Foucault-Fruchard L, Chalon S.

Fundam Clin Pharmacol. 2021 Jun;35(3):582-594. doi: 10.1111/fcp.12654. Epub 2021 Mar 8.

Associations Between Obesity and Alzheimer's Disease: Multiple Bioinformatic Analyses

Zhuang QS, Meng L, Wang Z, Shen L, Ji HF.

J Alzheimers Dis. 2021;80(1):271-281. doi: 10.3233/JAD-201235.

Preclinical and clinical biomarker studies of CT1812: A novel approach to Alzheimer's disease modification

Izzo NJ, Yuede CM, LaBarbera KM, Limegrover CS, Rehak C, Yurko R, Waybright L, Look G, Rishton G, Safferstein H, Hamby ME, Williams C, Sadlek K, Edwards HM, Davis CS, Grundman M, Schneider LS, DeKosky ST, Chelsky D, Pike I, Henstridge C, Blennow K, Zetterberg H, LeVine H 3rd, Spires-Jones TL, Cirrito JR, Catalano SM.

Alzheimers Dement. 2021 Aug;17(8):1365-1382. doi: 10.1002/alz.12302. Epub 2021 Feb 8.

Melatonin levels in the Alzheimer's disease continuum: a systematic review

Nous A, Engelborghs S, Smolders I.

Alzheimers Res Ther. 2021 Feb 23;13(1):52. doi: 10.1186/s13195-021-00788-6.

Alzheimer Disease Clinical Trials Targeting Amyloid: Lessons Learned From Success in Mice and Failure in Humans

Reiss AB, Montufar N, DeLeon J, Pinkhasov A, Gomolin IH, Glass AD, Arain HA, Stecker MM.

Neurologist. 2021 Mar 4;26(2):52-61. doi: 10.1097/NRL.0000000000000320.

Alzheimer's disease and its treatment by different approaches: A review

Srivastava S, Ahmad R, Khare SK.

Eur J Med Chem. 2021 Apr 15;216:113320. doi: 10.1016/j.ejmech.2021.113320. Epub 2021 Feb 23.

Imaging Techniques in Alzheimer's Disease: A Review of Applications in Early Diagnosis and Longitudinal Monitoring

van Oostveen WM, de Lange ECM.

Int J Mol Sci. 2021 Feb 20;22(4):2110. doi: 10.3390/ijms22042110.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias